Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers
- PMID: 27308358
- PMCID: PMC4904900
- DOI: 10.4161/23723548.2014.970055
Awakening the Hippo co-activator YAP1, a mercurial cancer gene, in hematologic cancers
Abstract
Unrestrained oncogene activity triggers DNA damage. Cancer cells exploit various stratagems to deal with this potentially lethal event. We found that hematologic cancer cells inactivate the Hippo co-activator Yes-associated protein 1 (YAP1). A synthetic lethal approach is proposed whereby inhibition of the serine/threonine kinase 4 (STK4) could be exploited to restore YAP1 levels in hematologic cancers.
Keywords: STK4; YAP-1; multiple myeloma; tumor suppressor.
Figures

References
-
- Halazonetis T.D, et al. . An oncogene-induced DNA damage model for cancer development. Science 2008; 319(5868):1352-5; PMID:18323444; http://dx.doi.org/10.1126/science.1140735 - DOI - PubMed
-
- Cottini F, et al. . Rescue of Hippo coactivator YAP1 triggers DNA damage-induced apoptosis in hematological cancers. Nat Med 2014; 20(6):599-606; PMID:24813251; http://dx.doi.org/10.1038/nm.3562 - DOI - PMC - PubMed
-
- Kharbanda S, et al, Functional role for the c-Abl protein tyrosine kinase in the cellular response to genotoxic stress. Biochim Biophys Acta, 1997; 1333(2):O1-7; PMID:9395286 - PubMed
-
- Yuan Z M, et al. , Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. Proc Natl Acad Sci U S A 1997; 94(4):1437-1440; PMID:9037071; http://dx.doi.org/10.1073/pnas.94.4.1437 - DOI - PMC - PubMed
-
- Levy D, et al. . Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage. Mol Cell 2008; 29(3):350-61; PMID:18280240; http://dx.doi.org/10.1016/j.molcel.2007.12.022 - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials